🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Contrast-enhanced magnetic resonance imaging is the most widely used examin...
Status
Completed
Location
CHU Amiens
Start Date
2022-02-01
Trial ID
NCT05762172
Treatments Being Tested
RATIONALE: New imaging procedures, such as fluorine F 18 fluorodopa-labeled...
Status
Completed
Location
Mayo Clinic
Start Date
2010-07-26
Trial ID
NCT01165632
This phase II trial studies how well the addition of 18F-DOPA (amino acid) ...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-03-24
Trial ID
NCT06667726
Treatments Being Tested
The purpose of this pilot study will be to conduct a clinical trial using a...
Status
Unknown
Location
University of Virginia
Start Date
2020-03-15
Trial ID
NCT04315584
This is a pilot study designed to evaluate the potential of using FDOPA-PET...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2015-03
Trial ID
NCT02371031
Treatments Being Tested
In this pilot study, the study evaluators will evaluate the ability of posi...
Status
Completed
Location
CHU de Nimes
Start Date
2020-12-16
Trial ID
NCT04566185
Treatments Being Tested
Single centre prospective cohort phase III study of 18F-DOPA PET/CT imaging...
Status
Completed
Location
University of Alberta Hospital
Start Date
2017-06-29
Trial ID
NCT03042416
Treatments Being Tested
It was previously shown that \[18F\]Fluorodopa (FDOPA) PET imaging results ...
Status
Terminated
Location
Houston Methodist Research Institute PET Center
Start Date
2014-05
Trial ID
NCT02176720
Treatments Being Tested
the investigators hypothesise that 18F-FDOPA PET kinetic parameters are goo...
Status
Recruiting
Location
CHRU Nancy
Start Date
2023-06-13
Trial ID
NCT05512403
Treatments Being Tested
About 20 to 30% of patients treated for cancer will have brain metastases. ...
Status
Completed
Location
CHU Angers
Start Date
2021-12-03
Trial ID
NCT04890028
Treatments Being Tested